Clinical trials in the time of COVID: Risks, mitigation and lessons learned
Clinical trials in the time of COVID: Risks, mitigation and lessons learned Stephanie Finnegan, COO of Cromos Pharma explores some of the major disruptions caused by the ongoing pandemic to clinical trials processes. In this presentation she looks at risks, how to mitigate crisis management, and what the sector has learned since being forced into some major changes due to COVID-19. This presentation was prepared January 2021
Global vaccine rollout underway as COVID-19 cases surge
Global vaccine rollout underway as COVID-19 cases surge Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).   The UK was the first country to approve use of the Pfizer/BioNTech vaccine with the first dose administered on December 8, 2020 and further doses rolled out to people over 80 years
JP Morgan Healthcare Conference: Virtual Booth and Daily Presentations
JP Morgan Healthcare Conference: Virtual Booth and Daily Presentations We have been meeting you at the JP Morgan Healthcare Conference for the past 11 years and there is no way we are going to break with this tradition. Meet us at CROMOS PHARMA VIRTUAL BOOTH January 11th through 14th from 8 am to 5 pm(PST). Learn about some of the most vital issues in clinical research by attending our

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us